(Q36985864)

17 August 2017

1 reference

title

Vaccination against nicotine: an emerging therapy for tobacco dependence (English)

1 reference

17 August 2017

2

Martin F Bachmann

1 reference

17 August 2017

Patrik Maurer

1

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Expert Opinion on Investigational Drugs

17 August 2017

published in

1 reference

17 August 2017

volume

16

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

1775-1783

1 reference

Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Clinical practice. Treatment of tobacco use and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Metabolism and disposition kinetics of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Is there a common molecular pathway for addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Neuropharmacology and potential efficacy of new treatments for tobacco dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Symptoms of tobacco withdrawal. A replication and extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Dopamine D3 receptor ligands for the treatment of tobacco dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Changes in heroin self-administration by a rhesus monkey after morphine immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Predicting smoking cessation. Who will quit with and without the nicotine patch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Nicotine and nonnicotine factors in cigarette addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

An immunotherapeutic program for the treatment of nicotine addiction: hapten design and synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Preclinical development of a vaccine 'against smoking'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

A new strategy for improved nicotine vaccines using conformationally constrained haptens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Active immunization against nicotine alters the distribution of nicotine but not the metabolism to cotinine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

The need for dissemination of evidence-based results from research on nicotine and tobacco

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Outcome criteria in smoking cessation trials: proposal for a common standard.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Immunization of rats reduces nicotine distribution to brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Tissue-dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Nicotine conjugate vaccine: is there a right to a smoking future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

Will nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.11.1775

10.1517/13543784.16.11.1775

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference